TRIM39 (RNF23) Antibody (YA8219)

(Synonyms: RNF23; TFP; TRIM39B)

TRIM39 (RNF23) Antibody (YA8219) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TRIM39 (RNF23).

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    IgG1

  • Application:

    WB

  • Reactivity :

    Human, Mouse, Rat

  • Formulation:

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
Dilution Ratio 1:500-2000

Product Details

Description

TRIM39 (RNF23) Antibody (YA8219) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TRIM39 (RNF23).

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human, Mouse, Rat
  • Calculated Molecular Weight Predicted band size: 56.2 kDa
Immunogen

Human recombinant protein fragment corresponding to amino acids 144-378 of human TRIM39 produced in E.coli.

Sensitivity

Endogenous

Purification

Affinity purified

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG1

Product Properties

  • Appearance

    Liquid

  • Formulation

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    TRIM39 is an E3 ubiquitin-protein ligase. May facilitate apoptosis by inhibiting APC/C-Cdh1-mediated poly-ubiquitination and subsequent proteasome-mediated degradation of the pro-apoptotic protein MOAP1. Regulates the G1/S transition of the cell cycle and DNA damage-induced G2 arrest by stabilizing CDKN1A/p21. Positively regulates CDKN1A/p21 stability by competing with DTL for CDKN1A/p21 binding, therefore disrupting DCX(DTL) E3 ubiquitin ligase complex-mediated CDKN1A/p21 ubiquitination and degradation |Regulates the G1/S transition of the cell cycle and DNA damage-induced G2 arrest by stabilizing CDKN1A/p21. Positively regulates CDKN1A/p21 stability by competing with DTL for CDKN1A/p21 binding, therefore disrupting DCX(DTL) E3 ubiquitin ligase complex-mediated CDKN1A/p21 ubiquitination and degradation. Negatively regulates the canonical NF-kappa-B signaling pathway via stabilization of CACTIN in an ubiquitination-independent manner[1][2][3][4].

  • Subcellular Localization

    Cytoplasm, cytosol,Mitochondrion,Nucleus,Nucleus

  • Expression


    Tissue_Specificity: Ubiquitous; highly expressed in brain, heart, kidney, liver, skeletal muscle, spleen and testis

  • Isoforms & Post-Translational Modification

    Q9HCM9 has two isomers: Q9HCM9-1: 59690 Da (predicted); Q9HCM9-2: 56374 Da (predicted).
    Autoubiquitinated

  • Subunit

    Isoform 1 interacts with MOAP1 (PubMed:19100260)

  • SwissProt ID

    Q9HCM9

  • Synonyms

    RNF23; TFP; TRIM39B

TRIM39 (RNF23) Antibody (YA8219) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00